Foster Dykema Cabot & Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.2M | Buy |
44,949
+62
| +0.1% | +$25.2K | 1.28% | 25 |
|
2025
Q1 | $22.4M | Sell |
44,887
-425
| -0.9% | -$212K | 1.79% | 20 |
|
2024
Q4 | $23.6M | Buy |
45,312
+2,173
| +5% | +$1.13M | 1.84% | 20 |
|
2024
Q3 | $26.7M | Sell |
43,139
-2
| -0% | -$1.24K | 2.24% | 16 |
|
2024
Q2 | $23.9M | Buy |
43,141
+424
| +1% | +$235K | 2.14% | 20 |
|
2024
Q1 | $24.8M | Buy |
42,717
+695
| +2% | +$404K | 2.31% | 17 |
|
2023
Q4 | $22.3M | Buy |
+42,022
| New | +$22.3M | 2.36% | 15 |
|